Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Directorate Change

6th Feb 2006 07:00

Ascribe plc06 February 2006 6 February 2006 Ascribe plc ("Ascribe" or "the Group") Appointment of non-executive director Ascribe (AIM:ASP), the health IT Group focusing on medicines management, ispleased to announce the appointment of Chris Dickson to the Board asnon-executive director, with immediate effect. Chris Dickson, aged 46, is currently CEO of Hybrid-4 Ltd, a company thatprovides mobile technology solutions for patient data collection andcommunication in the healthcare and pharmaceutical industries. Chris undertookhis medical education in London before training and working as a GP. In 1994 hejoined Independent British Healthcare later becoming operations director oftheir occupational health division. Chris then worked in Hong Kong for fiveyears where he managed the medical support for the construction of the newairport and later the global medical arrangements for Cathay Pacific Airways.Before joining Hybrid-4 Chris was Head of Health Care Services at BUPA in theUK. Commenting on the appointment, Stephen Critchlow, Executive Chairman, Ascribeplc, said: "I am delighted to welcome Chris to the Board of Ascribe. His strongbackground and experience will be of great benefit to the Company going forward." Ends - For further information: Stephen Critchlow, Executive Chairman Tel: +44(0) 161 280 8080 Email [email protected] Graham Lewis, Chief Executive Officer Tel: +44(0) 161 280 8080 Email [email protected] Ginny Pulbrook / Justin Griffiths, Citigate Dewe Rogerson Tel: +44 (0) 20 7638 9671 Notes to Editors: Chris Dickson Save as disclosed below, there is nothing further to disclose in relation toChris Dickson's appointment under schedule two, paragraph (f) of the AIM Rules. Past directorships: None Current directorships: Hybrid-4 Ltd As at 2 February 2006, Chris Dickson does not have a notifiable interest in theordinary share capital of the Company. About Ascribe plc Ascribe plc is a leading healthcare company that develops and markets softwaresolutions supporting patient, clinical and business processes to theinternational healthcare market. The Group provides solutions to Emergency andMinor Injuries units, Mental Health and Social Care units, Hospital and RetailPharmacies, and General Practice surgeries. The Group consists of: ASC Computer Software Ltd, Protechnic Exeter Ltd,Footman-Walker Associates Ltd & Park Systems Ltd. Ascribe plc was floated on AIM in 2004, and currently employs 150 personnelthough its four market leading companies in the UK, Hong Kong, Malaysia,Australia and New Zealand. For more information, please visit http://www.ascribe.com This information is provided by RNS The company news service from the London Stock Exchange

Related Shares:

ASP.L
FTSE 100 Latest
Value8,699.31
Change14.75